City-wide Surveillance for the Occurrence of Respiratory Syncytial Virus(RSV) Respiratory Tract Infections in a Population of High Risk Infants ≤32 weeks Gestational Age † 1453

被引:0
|
作者
Janine Y Khan
Beverly S Brozanski
机构
[1] RSV Pittsburgh Consortium,Department of Pediatrics
[2] University of Pittsburgh,undefined
[3] Magee-Womens Research Institute,undefined
关键词
D O I
10.1203/00006450-199804001-01474
中图分类号
学科分类号
摘要
引用
收藏
页码:248 / 248
相关论文
共 50 条
  • [21] Impact of the risk scoring model on the cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks in Canada
    Lanctot, K. L.
    Paes, B.
    Francis, P. L.
    Chiu, A.
    Hui, C.
    Oh, P., I
    VALUE IN HEALTH, 2008, 11 (03) : A248 - A249
  • [22] Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity
    Lanari, M
    Giovannini, M
    Giuffré, L
    Marini, A
    Rondini, G
    Rossi, GA
    Merolla, R
    Zuccotti, GV
    Salvioli, GP
    PEDIATRIC PULMONOLOGY, 2002, 33 (06) : 458 - 465
  • [23] Epidemiology of Respiratory Syncytial Virus Infection in Infants Born at Less Than Thirty-Five Weeks of Gestational Age
    Park, Hye Won
    Lee, Byong Sop
    Kim, Ai-Rhan
    Yoon, Hye Sun
    Kim, Beyong Il
    Song, Eun Song
    Kim, Woo Taek
    Lim, JaeWoo
    Kim, SeungYeon
    Jin, Hyun-Seung
    Byun, ShinYun
    Chee, Dong Hyun
    Kim, Ki-Soo
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (08) : E99 - E104
  • [24] Safety of Palivizumab in Preterm Infants 29 to 32 Weeks' Gestational Age Without Chronic Lung Disease to Prevent Serious Respiratory Syncytial Virus Infection
    J. R. Groothuis
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 414 - 417
  • [25] Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection
    Groothuis, JR
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (07) : 414 - 417
  • [26] Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey: author's reply
    Oncel, Mehmet Yekta
    Alyamac-Dizdar, Evrim
    Erdeve, Omer
    Oguz, Suna
    Dilmen, Ugur
    TURKISH JOURNAL OF PEDIATRICS, 2013, 55 (05) : 568 - 568
  • [27] FLIP-2 study -: Risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks
    Figueras-Aloy, Jose
    Carbonell-Estrany, Xavier
    Quero-Jimenez, Jose
    Fernandez-Colomer, Belen
    Guzman-Cabanas, Juana
    Echaniz-Urcelay, Innaqui
    Domenech-Martinez, Eduardo
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (09) : 788 - 793
  • [28] A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33–35 weeks of gestational age, based on data from the Spanish FLIP study
    Eric AF Simões
    Xavier Carbonell-Estrany
    John R Fullarton
    Johannes G Liese
    Jose Figueras-Aloy
    Gunther Doering
    Juana Guzman
    Respiratory Research, 9
  • [29] Clinical characteristics and risk factors of severe respiratory syncytial virus-associated acute lower respiratory tract infections in hospitalized infants
    Zhang, Xiao-Bo
    Liu, Li-Juan
    Qian, Li-Ling
    Jiang, Gao-Li
    Wang, Chuan-Kai
    Jia, Phi
    Shi, Peng
    Xu, Jin
    Wang, Li-Bo
    WORLD JOURNAL OF PEDIATRICS, 2014, 10 (04) : 360 - 364
  • [30] Clinical characteristics and risk factors of severe respiratory syncytial virus-associated acute lower respiratory tract infections in hospitalized infants
    Xiao-Bo Zhang
    Li-Juan Liu
    Li-Ling Qian
    Gao-Li Jiang
    Chuan-Kai Wang
    Pin Jia
    Peng Shi
    Jin Xu
    Li-Bo Wang
    World Journal of Pediatrics, 2014, 10 : 360 - 364